Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy

University of Campania Luigi Vanvitelli

Overview

The purpose of this study is to evaluate the role, the safety and the effectiveness of Intravitreal Bevacizumab injections as an adjunct to vitrectomy in the management of severe proliferative diabetic retinopathy.

Study Type

INTERVENTIONAL

Purpose

TREATMENT

Conditions

Proliferative Diabetic Retinopathy

Interventions

BevacizumabDRUG

shamOTHER

Eligibility

Sex: ALLHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * vitreous haemorrhage * tractional retinal detachment * active proliferative diabetic retinopathy. Exclusion Criteria: * neovascular glaucoma * cataract * combined traction and rhegmatogenous RD

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.